The response of XPC knockdown was comparable to those observed in DLD-1 BAX–BAK DKO cells (IC50 value > 40 μmol; RF = 13.22) suggesting the enhancing role of XPC in the development of resistance in DLD-1 colon cancer cells model against chemotherapy. This evidence concerns the gene BAK1 and malignant colon neoplasm.